$0.925
+0.017 (+1.79%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による GDTC の予測・予想
Alphio's GDTC stock price prediction model matches the current CytoMed Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.94 (+1.76%). The 1-week path is $0.98 (+6.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
CytoMed Therapeutics Ltd 株は買うべき？
CytoMed Therapeutics Ltd (GDTC) is not a good buy right now due to its significant downward trends and poor financial metrics. The current price is $0.92, which is down 33.81% year-to-date and 54.11% over the past year. Additionally, the stock has a negative P/E ratio of -1.91 and a forward P/E of 0, indicating a lack of profitability and future earnings potential. The RSI is at 46.19, suggesting the stock is neither overbought nor oversold, but the overall trend is negative. The main risk is the 5-day change of -10.68%, indicating a recent sharp decline in value.
GDTC の株価は Tuesday に $0.93 で引け、その前に上昇 +1.79%
CytoMed Therapeutics Ltd (GDTC) last closed at $0.925, gaining +1.79%. These facts feed the 1-day and 1-week GDTC price prediction above.
予想の要因
CytoMed Therapeutics Ltd（GDTC）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
類似チャートパターン
直近の値動きが GDTC に最も近い銘柄を、類似度順に表示します。
GDTC の季節性分析
Historically the probability of a positive September return for GDTC is 0.00%. January offers the highest probability of a positive month at 4.92%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。